Parkinson’s disease is a progressive brain disorder that affects millions of people worldwide. It causes tremors, muscle stiffness, and difficulty with movement and balance, and symptoms worsen over time.
While doctors still do not know the exact cause of Parkinson’s, researchers have been exploring different factors that might contribute to its development—including the use of epilepsy medications.
A recent study by Queen Mary University of London suggests that antiepileptic drugs may be linked to an increased risk of Parkinson’s disease. The research, published in JAMA Neurology, analyzed data from 1,433 people with Parkinson’s disease and 8,598 healthy individuals to see if epilepsy medications were connected to the condition.
What the Study Found
The researchers examined prescription records to determine how often patients had taken antiepileptic drugs, including:
- Carbamazepine
- Lamotrigine
- Levetiracetam
- Sodium valproate
They discovered that people who had been prescribed higher doses or multiple types of these medications had a greater risk of developing Parkinson’s disease. This means that the more often a person took these drugs, the higher their chances of developing Parkinson’s.
This is the first study to examine a wide range of epilepsy medications in relation to Parkinson’s disease, making it an important contribution to medical research. However, the study does not prove that these drugs directly cause Parkinson’s—only that there is a possible connection that needs further investigation.
What This Means for Patients
While this finding is concerning, antiepileptic drugs remain essential for people with epilepsy and other seizure disorders. These medications help prevent life-threatening seizures, so their benefits often outweigh the risks. Doctors and patients should carefully consider both the risks and benefits before making any changes to epilepsy treatment.
The Need for More Research
The study raises many important questions:
- Why might epilepsy drugs be linked to Parkinson’s?
- Are some medications riskier than others?
- Do people with epilepsy already have a higher risk of Parkinson’s, regardless of medication?
Scientists need to conduct more studies to answer these questions and understand the underlying biological reasonsbehind this link.
This research highlights the importance of monitoring medication effects over time. It also encourages doctors to be cautious when prescribing long-term epilepsy treatments, especially for patients who might already be at risk of developing Parkinson’s.
The Bottom Line
This study is an important step in understanding the possible risks of epilepsy medications. While more research is needed, it provides useful information for doctors and patients when making treatment decisions. As scientists continue to study Parkinson’s disease and its causes, findings like this could help lead to better prevention and treatment strategies in the future.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2025 Knowridge Science Report. All rights reserved.
